JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist

54
+4+8.00%

20min DelayNot Open Nov 21 15:30 JST

4.52BMarket Cap-2965P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

-98.64%72K

-90.20%5K

-99.54%23K

-61.64%28K

-84.91%16K

-65.73%5.28M

-99.66%51K

7,437.31%5.05M

43.14%73K

-50.00%106K

Cost of revenue

-99.05%18K

-99.67%2K

-99.60%5K

-61.11%7K

-84.62%4K

-42.87%1.9M

-81.05%613K

7,182.35%1.24M

50.00%18K

-50.94%26K

Gross profit

-98.40%54K

100.71%4K

-99.55%17K

-61.82%21K

-84.81%12K

-72.01%3.38M

-104.75%-562K

7,524.00%3.81M

44.74%55K

-50.31%79K

Operating expense

-21.44%1.16B

-16.21%207.91M

-4.91%396.62M

-0.98%257.16M

-46.21%293.45M

-1.19%1.47B

-40.09%248.13M

18.40%417.12M

-18.57%259.7M

35.45%545.5M

Operating profit

21.27%-1.16B

16.40%-207.91M

4.04%-396.6M

0.97%-257.14M

46.20%-293.44M

0.61%-1.47B

38.19%-248.69M

-17.33%-413.3M

18.58%-259.64M

-35.48%-545.42M

Net non-operating interest income (expenses)

35.04%-1.39M

-1,598.78%-1.39M

101.35%6K

15.68%-2.14M

92.65%-82K

-991K

47.89%-445K

-9.79%-617K

Non-operating interest income

-40.00%12K

-33.33%6K

--0

----

-25.93%20K

-30.77%9K

--0

----

Non-operating interest expense

--0

----

-83.15%61K

----

Total other finance cost

-33.19%1.4M

----

-4.69%2.09M

-96.09%30K

--991K

-47.47%456K

9.79%617K

Net investment income

44.86%-2.66M

-167.29%-2.15M

431.25%680K

67.17%-564K

74.22%-626K

-38.96%-4.82M

67.76%-804K

135.75%128K

-1,180.50%-1.72M

-212.48%-2.43M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

27.17%-7.25M

74.97%-2.49M

-3.35M

-1.41M

-5,822.99%-9.96M

-1,088.88%-9.96M

Less:Write off

-27.17%7.25M

-74.97%2.49M

--3.35M

--0

--1.41M

74.67%9.96M

2,178.72%9.96M

--0

Other non-operating income (expenses)

-18.67%196K

140.98%100K

-90K

-24.70%186K

170.79%241K

-244K

561.11%238K

2,987.50%247K

Income before tax

21.40%-1.17B

17.68%-213.84M

3.57%-399.37M

1.48%-257.69M

46.14%-295.28M

-0.13%-1.48B

35.84%-259.78M

-16.95%-414.17M

18.34%-261.57M

-36.24%-548.22M

Income tax

0.00%1.9M

0.00%475K

-21.49%1.9M

-21.49%475K

Net income

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

-36.16%-548.7M

Net income continuous operations

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

-36.16%-548.7M

Noncontrolling interests

Net income attributable to the company

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

-36.16%-548.7M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

-36.16%-548.7M

Gross dividend payment

Basic earnings per share

26.87%-18.21

23.06%-3.07

5.66%-6.33

7.64%-4.11

51.79%-4.7

12.78%-24.9

47.43%-3.99

0.74%-6.71

29.03%-4.45

-22.95%-9.75

Diluted earnings per share

26.87%-18.21

25.81%-3.07

5.66%-6.33

7.64%-4.11

51.79%-4.7

12.78%-24.9

45.48%-4.1381

0.91%-6.71

29.03%-4.45

-22.95%-9.75

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	-98.64%72K	-90.20%5K	-99.54%23K	-61.64%28K	-84.91%16K	-65.73%5.28M	-99.66%51K	7,437.31%5.05M	43.14%73K	-50.00%106K
Cost of revenue	-99.05%18K	-99.67%2K	-99.60%5K	-61.11%7K	-84.62%4K	-42.87%1.9M	-81.05%613K	7,182.35%1.24M	50.00%18K	-50.94%26K
Gross profit	-98.40%54K	100.71%4K	-99.55%17K	-61.82%21K	-84.81%12K	-72.01%3.38M	-104.75%-562K	7,524.00%3.81M	44.74%55K	-50.31%79K
Operating expense	-21.44%1.16B	-16.21%207.91M	-4.91%396.62M	-0.98%257.16M	-46.21%293.45M	-1.19%1.47B	-40.09%248.13M	18.40%417.12M	-18.57%259.7M	35.45%545.5M
Operating profit	21.27%-1.16B	16.40%-207.91M	4.04%-396.6M	0.97%-257.14M	46.20%-293.44M	0.61%-1.47B	38.19%-248.69M	-17.33%-413.3M	18.58%-259.64M	-35.48%-545.42M
Net non-operating interest income (expenses)	35.04%-1.39M	-1,598.78%-1.39M	0	101.35%6K	0	15.68%-2.14M	92.65%-82K	-991K	47.89%-445K	-9.79%-617K
Non-operating interest income	-40.00%12K	-33.33%6K	--0	----	----	-25.93%20K	-30.77%9K	--0	----	----
Non-operating interest expense	--0	----	----	----	----	-83.15%61K	----	----	----	----
Total other finance cost	-33.19%1.4M	----	----	----	----	-4.69%2.09M	-96.09%30K	--991K	-47.47%456K	9.79%617K
Net investment income	44.86%-2.66M	-167.29%-2.15M	431.25%680K	67.17%-564K	74.22%-626K	-38.96%-4.82M	67.76%-804K	135.75%128K	-1,180.50%-1.72M	-212.48%-2.43M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	27.17%-7.25M	74.97%-2.49M	-3.35M	0	-1.41M	-5,822.99%-9.96M	-1,088.88%-9.96M	0	0	0
Less:Write off	-27.17%7.25M	-74.97%2.49M	--3.35M	--0	--1.41M	74.67%9.96M	2,178.72%9.96M	--0	--0	--0
Other non-operating income (expenses)	-18.67%196K	140.98%100K	-90K	0	-24.70%186K	170.79%241K	-244K	0	561.11%238K	2,987.50%247K
Income before tax	21.40%-1.17B	17.68%-213.84M	3.57%-399.37M	1.48%-257.69M	46.14%-295.28M	-0.13%-1.48B	35.84%-259.78M	-16.95%-414.17M	18.34%-261.57M	-36.24%-548.22M
Income tax	0.00%1.9M	0.00%475K	0.00%475K	0.00%475K	0.00%475K	-21.49%1.9M	-21.49%475K	-21.49%475K	-21.49%475K	-21.49%475K
Net income	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M	-36.16%-548.7M
Net income continuous operations	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M	-36.16%-548.7M
Noncontrolling interests
Net income attributable to the company	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M	-36.16%-548.7M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M	-36.16%-548.7M
Gross dividend payment
Basic earnings per share	26.87%-18.21	23.06%-3.07	5.66%-6.33	7.64%-4.11	51.79%-4.7	12.78%-24.9	47.43%-3.99	0.74%-6.71	29.03%-4.45	-22.95%-9.75
Diluted earnings per share	26.87%-18.21	25.81%-3.07	5.66%-6.33	7.64%-4.11	51.79%-4.7	12.78%-24.9	45.48%-4.1381	0.91%-6.71	29.03%-4.45	-22.95%-9.75
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data